BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 1423273)

  • 1. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
    Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD
    Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
    Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
    Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
    Jarvis WD; Povirk LF; Turner AJ; Traylor RS; Gewirtz DA; Pettit GR; Grant S
    Biochem Pharmacol; 1994 Mar; 47(5):839-52. PubMed ID: 8135859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the expression of Bcl-2 and related proteins in human leukemia cells by protein kinase C activators: relationship to effects on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis.
    Bartimole TM; Vrana JA; Freemerman AJ; Jarvis WD; Reed JC; Boise LH; Grant S
    Cell Death Differ; 1997 May; 4(4):294-303. PubMed ID: 16465244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S; Boise L; Westin E; Howe C; Pettit GR; Turner A; McCrady C
    Biochem Pharmacol; 1991 Jul; 42(4):853-67. PubMed ID: 1867641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
    Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
    Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure.
    Vrana JA; Rao AS; Wang Z; Jarvis WD; Grant S
    Int J Oncol; 1998 Apr; 12(4):927-34. PubMed ID: 9499457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.
    Cragg LH; Andreeff M; Feldman E; Roberts J; Murgo A; Winning M; Tombes MB; Roboz G; Kramer L; Grant S
    Clin Cancer Res; 2002 Jul; 8(7):2123-33. PubMed ID: 12114412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
    Ross DD; Chen SR; Cuddy DP
    Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.
    Rao AS; Freemerman AJ; Jarvis WD; Chelliah J; Bear HD; Mikkelsen R; Grant S
    Leukemia; 1996 Jul; 10(7):1150-8. PubMed ID: 8683995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
    Chelliah J; Freemerman AJ; Wu-Pong S; Jarvis WD; Grant S
    Biochem Pharmacol; 1997 Sep; 54(5):563-73. PubMed ID: 9337072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the activity of nitric oxide by the protein kinase C activator phorbol ester in human myeloid leukemic HL-60 cells: association with enhanced fragmentation of mature genomic DNA.
    Jun CD; Park SJ; Choi BM; Kwak HJ; Park YC; Kim MS; Park RK; Chung HT
    Cell Immunol; 1997 Feb; 176(1):41-9. PubMed ID: 9070316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
    Wang S; Wang Z; Grant S
    Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
    Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K
    Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
    Clark CS; Konyer JE; Meckling KA
    Exp Cell Res; 2004 Mar; 294(1):301-11. PubMed ID: 14980523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S; Bhalla K; Rauscher F; Cadman E
    Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of 1-beta-D-arabinofuranosylcytosine cytotoxicity in human tumor cells by inhibiting drug efflux.
    Chan TC
    Cancer Res; 1989 May; 49(10):2656-60. PubMed ID: 2713849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.